Glutamatergic signaling abnormalities in cortico-striatal circuits are hypothesized to lead to the repetitive thoughts and behaviors of obsessive-compulsive disorder (OCD). To test this hypothesis, studies have used proton magnetic resonance spectroscopy ( 1 H MRS) to measure glutamatergic compounds in the striatum of individuals with OCD. However, no studies have used methods that could measure glutamate minimally contaminated by glutamine and γ-aminobutyric acid (GABA) in striatal subregions. Therefore, in this study, a proton MRS imaging ( 1 H MRSI) technique with relatively high spatial resolution at 3.0 T was used to measure minimally contaminated glutamate levels in three striatal subregions (i.e., dorsal caudate, dorsal putamen, and ventral striatum) in 15 unmedicated adults with OCD and 16 matched healthy control subjects. No significant group differences in glutamate levels were found in any of the three striatal subregions. In contrast, a study in unmedicated pediatric OCD patients that measured glutamatergic compounds in the dorsal caudate by MRS at 1.5 T found significant elevations. Further studies are warranted to assess whether these discrepant MRS findings are due to differences in subject age or MRS methodology, or potentially are associated with glutamatergic gene variants implicated in OCD.
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Introduction
Structural and functional imaging studies indicate that obsessive-compulsive disorder (OCD) is associated with abnormal functioning of brain circuits that include the orbito-frontal cortex (OFC), anterior cingulate cortex (ACC), striatum, and thalamus (Milad and Rauch, 2012) . Preclinical and clinical evidence suggests a role for glutamatergic abnormalities in OCD, including reports of associations between OCD and genes related to the glutamate system, of OCD-like behavior in mice following disruption of glutamatergic transmission in cortico-striatal circuits, and of the ability of glutamate-modulating drugs to ameliorate OCD symptoms (reviewed in Insel, 2012; Pittenger et al., 2011) . Together, these observations have led to the hypothesis that abnormalities in glutamatergic signaling in OFC-striatal circuits may be implicated in the repetitive thoughts and behaviors that characterize OCD.
Several studies have tested this hypothesis by using proton magnetic resonance spectroscopy ( 1 H MRS) to measure levels of glutamatergic compounds in the striatum of individuals with OCD and healthy control subjects (reviewed in Brennan et al., 2012) . The results have been variable, with one study reporting elevations of glutamatergic compounds in the head of the left caudate in unmedicated pediatric patients that decreased with successful treatment (Rosenberg et al., 2000) , another study reporting elevated glutamatergic compounds in the left caudate in medicated adult patients (Shekhar et al., 2008) , and the majority of studies in both pediatric and adult patients finding no striatal glutamatergic abnormalities (Bartha et al., 1998a; Ebert et al., 1997; Lazaro et al., 2012; O'Neill et al., 2012; Starck et al., 2008; Whiteside et al., 2006 Whiteside et al., , 2012 
